DLK2 Acts as a Potential Prognostic Biomarker for Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis

DLK2 Acts as a Potential Prognostic Biomarker for Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis

Clear cell renal cell carcinoma (ccRCC) is the most common RCC subtype with a high mortality. It has been reported that delta-like 1 homologue (DLK1) participates in the tumor microenvironmental remodeling of ccRCC, but the relationship between delta-like 2 homologue (DLK2, a DLK1 homologue) and ccR...

Full description

Bibliographic Details
Main Authors: Man-Gang Lee, Yung-Kuo Lee, Shih-Chung Huang, Chen-Lin Chang, Chou-Yuan Ko, Wen-Chin Lee, Tung-Yuan Chen, Shiow-Jyu Tzou, Cheng-Yi Huang, Ming-Hong Tai, Yu-Wei Lin, Mei-Lang Kung, Ming-Chao Tsai, Yung-Lung Chen, Yi-Chen Chang, Zhi-Hong Wen, Chao-Cheng Huang, Tian-Huei Chu
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Genes
Subjects:
clear cell renal cell carcinoma
delta-like 2 homologue
prognosis
biomarker
Online Access:https://www.mdpi.com/2073-4425/13/4/629

Internet

https://www.mdpi.com/2073-4425/13/4/629

Similar Items